Lenvatinib Interactions
There are 316 drugs known to interact with lenvatinib, along with 14 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 70 are major, 244 are moderate, and 2 are minor.
- View all 316 medications that may interact with lenvatinib
- View lenvatinib alcohol/food interactions (1)
- View lenvatinib disease interactions (14)
Most frequently checked interactions
View interaction reports for lenvatinib and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Activated Charcoal (charcoal)
- Align (bifidobacterium infantis)
- Allegra (fexofenadine)
- Asmanex Twisthaler (mometasone)
- Aspirin Low Strength (aspirin)
- Atarax (hydroxyzine)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Compazine (prochlorperazine)
- Eliquis (apixaban)
- Keytruda (pembrolizumab)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Protonix (pantoprazole)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
- Xarelto (rivaroxaban)
- Zofran (ondansetron)
Lenvatinib alcohol/food interactions
There is 1 alcohol/food interaction with lenvatinib.
Lenvatinib disease interactions
There are 14 disease interactions with lenvatinib which include:
- arterial thromboembolism
- bleeding
- cardiac dysfunction
- diarrhea
- GI perforation
- hepatic impairment
- hypertension
- hypocalcemia
- hypothyroidism
- proteinuria
- QT prolongation
- renal impairment
- RPL syndrome
- lung toxicity
More about lenvatinib
- lenvatinib consumer information
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Armour Thyroid
Armour Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid ...
NP Thyroid
NP Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid cancer ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Dabrafenib
Dabrafenib is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer, solid ...
Trametinib
Trametinib is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer, solid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.